Three leading organizations focused on scleroderma advocacy and research are partnering during June’s Scleroderma Awareness Month in order to boost awareness and compassion for those who suffer from the disease and their families. The Scleroderma Foundation, Scleroderma Research Foundation and Scleroderma Society of Canada are the primary partners in the effort. This…
News
An expert surgical team conducted the first lung reduction surgery in India. The recipient of the new, size-reduced lung was a 30-year-old woman named Mrs. Anita Devi, who suffers from scleroderma. The surgery was conducted to treat Mrs. Devi’s scleroderma-related pulmonary fibrosis, but the technique can be applied to a…
A review study recently published in the journal Arthritis Research & Therapy suggests that borderline pulmonary pressure in patients with scleroderma can represent a condition of pre-pulmonary arterial hypertension (PAH). The study was conducted by researchers at the Medical University of Graz and the Ludwig…
Bob Saget will once again host the 34th Cool Comedy – Hot Cuisine gala to benefit the Scleroderma Research Foundation (SRF). It will be held on Friday, June 5 at the Four Seasons Beverly Wilshire. Saget, who lost his sister to scleroderma and currently serves as an SRF Board Member, will appear along with friends and…
Researchers at the University of Padova and Spedali Civili di Brescia in Italy conducted a review focused on the role of autoantibodies in myositis and the different clinical phenotypes associated with them. The study was published in the journal Autoimmunity Highlights and is entitled “…
A new study recently published in the journal Annals of the Rheumatic Diseases revealed that the drug sildenafil can help on the healing of digital ulcers in patients with systemic sclerosis. The study is entitled “Efficacy of sildenafil on ischaemic digital ulcer healing in…
Researchers at Oslo University Hospital – Rikshospitalet and the University of Oslo in Norway recently published in the journal Arthritis & Rheumatology the finding that high-resolution computed tomography (HRCT) imaging can be used as a predictor of lung function in patients with systemic sclerosis. The…
Patients with Systemic Sclerosis (SS), also known as scleroderma, have the highest risk of developing pulmonary arterial hypertension (PAH), according to PH expert Harrison Farber, MD who recently presented his findings at the American College of Rheumatology State-of-the-Art Clinical Symposium. Farber presented data showing that 60% of patients with PAH are…
Fibrocell Science, Inc., an autologous gene and cell therapy firm developing first-in-class treatments to address scleroderma and connective tissue-related diseases, recently announced that the United States Food and Drug Administration (FDA) has awarded a rare pediatric disease designation for FCX-007. This is the Fibrocell’s main orphan gene-therapy drug candidate to treat recessive dystrophic epidermolysis bullosa…
The Strategic Pharma-Academic Research Consortium for Translational Medicine has announced it is providing new grants that will support research into autoimmune diseases worth $1.9 million in total. The consortium is led by the Indiana Clinical and Translational Sciences Institute and is offering financial support for research projects involving scleroderma, dermatomyositis, lupus, multiple sclerosis and Crohn’s disease. Other…
Recent Posts
- Lack of small blood vessel damage patterns may predict milder SSc
- Wireless sensor may help track scleroderma skin changes at home
- New scleroderma survey seeks patient input to guide future research
- Scleroderma added to NIH project targeting autoimmune diseases
- Off-the-shelf cell therapy shows early promise as scleroderma treatment
- Trial to test scleroderma treatments at earliest stages of disease
- Off-label JAK inhibitors may stabilize lung function in systemic sclerosis
- Distinct symptom pattern found for triple-negative scleroderma patients
- Plant-based nanoparticle therapy eases skin thickening in SSc: Study
- Specialized MRI scans may catch early lung damage in scleroderma